3rd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for KNOA PHARMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring legislative and regulatory activities impacting the pharmaceutical industry

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
WILLIAM MOSCHELLA New PrincAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs Judic Comm,ChfInvestigativeCouns Hs Judic Comm,GC Hs Rules Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm,SrLegAsst Rep Frank Wolf,LegAsst RepFrank Wolf,ComputerSysManager Rep Frank Wolf
ALFRED MOTTUR —

Banking BAN

Monitoring legislative related to changes affecting corporate bankruptcy including issues related to third party releases

LobbyistCovered position, as disclosed
WILLIAM MOSCHELLA —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.